KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Issued (2018 - 2025)

Historic Shares Issued for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $2.0 million.

  • Aurinia Pharmaceuticals' Shares Issued rose 39454.09% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 7942.51%. This contributed to the annual value of $8.2 million for FY2024, which is 5375.66% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Shares Issued of $2.0 million as of Q3 2025, which was up 39454.09% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Shares Issued ranged from a high of $181.4 million in Q4 2021 and a low of $167000.0 during Q4 2022
  • Its 5-year average for Shares Issued is $13.4 million, with a median of $1.4 million in 2022.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Shares Issued crashed by 9990.79% in 2022, and later soared by 73532.93% in 2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Shares Issued (Quarter) stood at $181.4 million in 2021, then plummeted by 99.91% to $167000.0 in 2022, then soared by 735.33% to $1.4 million in 2023, then grew by 18.21% to $1.6 million in 2024, then grew by 20.86% to $2.0 million in 2025.
  • Its Shares Issued stands at $2.0 million for Q3 2025, versus $1.3 million for Q2 2025 and $9.3 million for Q1 2025.